This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Van Vleet, T. R. Articles by Coulombe, R. A. Search for Related Content PubMed PubMed Citation Articles by Van Vleet, T. R. Articles by Coulombe, R. A., Jr.

Comparative Aflatoxin B₁ Activation and Cytotoxicity in Human Bronchial Cells Expressing Cytochromes P450 1A2 and 3A4¹

Graduate Program in Toxicology, Department of Veterinary Sciences, Utah State University, Logan, Utah 84322-4620 [T. R. V. V., R. A. C.], and Nestle Research Centre, Lausanne 26, Switzerland [K. M.]

Some epidemiological evidence suggests a link between the inhalation of aflatoxin B₁ (AFB₁)-contaminated grain dusts and increased lung cancer risk. However, the mechanisms of AFB₁ activation and action in human lung are not well understood. We compared AFB₁ action in SV40 immortalized human bronchial epithelial cells (BEAS-2B) with two transfected cell lines that stably express human cytochromes P450 (CYPs) 1A2 (B-CMV1A2) and 3A4 (B3A4), the principal CYPs thought to activate this mycotoxin in human liver. All three cell types retained catalytically active glutathione S-transferase, the key phase II enzyme that detoxifies metabolically activated AFB₁. B-CMV1A2 and B3A4 cells expressed methoxyresorufin-O-demethylase (MROD) and nifedipine oxidase activities, respectively, and were 3000- and 70-fold more susceptible, respectively, to the cytotoxic effects of AFB₁ than the control cell line (BEAS-2B). When cultured with a range of low, environmentally relevant AFB₁ concentrations (0.02–1.5 µM), control cells formed barely detectable AFB₁-DNA adducts, whereas B-CMV1A2 cells formed significantly more adducts than B3A4 cells. In B-CMV1A2 cells, formation of AFB₁-DNA adducts was inhibited by the CYP 1A2 inhibitor 7,8-benzoflavone, whereas formation of AFB₁-DNA adducts in B3A4 cells was inhibited by the CYP 3A4 inhibitor 17-ethynylestradiol. Competitive reverse transcription-PCR analysis showed that only the CYP-transfected cell lines expressed CYP mRNA. When adjusted for CYP mRNA expression, B-CMV1A2 cells were more efficient in the formation of cytotoxic and DNA-alkylating species at low AFB₁ concentrations, whereas B3A4 cells were more efficient at high concentrations. Our results affirm the hypothesis that, as in human liver microsomes, CYP 1A2 in human lung cells appears to have a more important role than CYP 3A4 in the bioactivation of low AFB₁ concentrations associated with many human exposures. Therefore, it is possible that under conditions in which appropriate CYPs are expressed in lung, inhalation of AFB₁ may result in increased risk of lung cancer in exposed persons.

This article has been cited by other articles:

				T. R. Van Vleet, T. L. Watterson, P. J. Klein, and R. A. Coulombe Jr. Aflatoxin B1 Alters the Expression of p53 in Cytochrome P450-Expressing Human Lung Cells Toxicol. Sci., February 1, 2006; 89(2): 399 - 407. [Abstract] [Full Text] [PDF]

				O. Kourylko, C. Fradette, M. Arcand, and P. du Souich MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6 Drug Metab. Dispos., January 1, 2006; 34(1): 27 - 35. [Abstract] [Full Text] [PDF]

				J. Z. Peng, R. P. Remmel, and R. J. Sawchuk INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES Drug Metab. Dispos., August 1, 2004; 32(8): 805 - 812. [Abstract] [Full Text] [PDF]